88IV - Public company info - Austar Lifesciences Ltd.

Input the stock code or the company name

Austar Lifesciences Ltd., 06118.HK - Cash Flow	2019-12	2018-12	2017-12	2016-12	2015-12	2014-12	2013-12	2012-12
Net Cash Flow from Operating Activities	35,545	-79,199	-8,008	-28,195	65,665	-36,315	86,673	80,113
Net Cash Flow from Return on Investments & Servicing of Finance	1,844	4,814	4,534	5,231	-14,725	-880	536	29
Interest Received	5,194	4,574	3,847	4,223	3,046	1,271	1,193	410
Interest Paid	-3,350	-1,448	-1,224	-1,081	-2,029	-2,091	-1,373	-1,629
Dividend Received	0	0	1,911	2,089	4,513	5,929	716	1,248
Dividend Paid	0	1,688	0	0	-20,255	-5,989	0	0
Others	0	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	-2,946	-2,973	-2,010	-5,773	-7,185	-29,357	-16,459	-6,542
Net Cash Flow from Investing Activities	-22,087	-41,183	25,594	-62,502	-29,469	12,785	-45,265	-26,007
Additions to Fixed Assets	-13,725	-37,405	-9,097	-11,014	-14,174	-11,769	-11,049	-5,950
Disposal of Fixed Assets	26	22	0	653	16	99	37	14
Increase in Investments	-7,451	-31	0	-15,874	1,338	-10,000	-76,708	-19,672
Decrease in Investments	0	0	0	0	0	35,000	50,000	0
Net Cash Flow with Related Parties	-1,406	0	2,058	0	0	-37,833	15,627	18,515
Others	469	-3,769	32,633	-36,267	-16,649	37,288	-23,172	-18,914
Net Cash Flow before Financing Activities	12,356	-118,541	20,110	-91,239	14,286	-53,767	25,485	47,593
Net Cash Flow from Financing Activities	-17,344	5,888	2,058	-15,000	0	296,852	11,627	18,515
New Loans	25,000	25,888	35,000	20,000	55,000	35,000	0	24,000
Loans Repayment	-40,938	-20,000	-35,000	-35,000	-55,000	-20,000	-4,000	-24,000
Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	0	0	0	0	0	0	0	0
Equity Financing	0	0	0	0	0	319,685	0	0
Net Cash Flow with Related Parties	-1,406	0	2,058	0	0	-37,833	15,627	18,515
Others	0	0	0	0	0	0	0	0
Increase(Decrease) in Cash & Cash Equivalents	-4,988	-112,653	22,168	-106,239	14,286	243,085	37,112	66,108
Cash & Cash Equivalents at Beginning of Year	196,459	309,320	286,352	393,383	382,624	139,712	102,611	37,499
Net Cash Flow due to Change in Exchange Rate/Others	-387	-208	800	-792	-3,527	-173	-11	-996
Cash & Cash Equivalents at End of Year	191,084	196,459	309,320	286,352	393,383	382,624	139,712	102,611
Currency	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi	Renminbi
Unit
Auditor's Opinion	1	1	1	1	1	1	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Austar Lifesciences Ltd. , 06118.HK